J Korean Assoc Maxillofac Plast Reconstr Surg.  2004 Mar;26(2):215-223.

A CASE REPORT OF TREATMENT OF MASSETERIC HYPERTROPHY WITH BOTULINUM TOXIN

Affiliations
  • 1Department of Oral and Maxillofacial Surgery, Dentistry, Muju Health Hospital, Korea. omschoi@hanmail.net

Abstract

The treatment of hypertrophy of the masseter has to been dominated by conservative and surgical measures. Local therapy with type A botulinum toxin permits an alternative method of treatment. After targeted, intramuscular injection of the affected muscles, marked inactivity atrophy occurred in the muscles of patients over the course of 3 to 8 weeks. It has been proven that the atrophy remained constant over a long peroid and no side effects were abserved. Because of its minimal invasiveness, this technique seems to have an advantage over conventional surgical therapy. Consequently, treatment with type A botulinum toxin can be regarded as a sensible alternative to surgery in cases of hypertrophy of the masseter muscles.

Keyword

Hypertrophy; Masster; Botulinum toxin

MeSH Terms

Atrophy
Botulinum Toxins*
Humans
Hypertrophy*
Injections, Intramuscular
Masseter Muscle
Muscles
Botulinum Toxins
Full Text Links
  • JKAMPRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr